Emsam was previously marketed and distributed by Bristol-Myers Squibb through a commercialization agreement. The transfer of distribution, marketing and sales to Dey concludes the three-year agreement with Bristol-Myers.
Catalyst intends to investigate the reasons for the disparity between the trial results and previously published clinical and non-clinical results evaluating vigabatrin as a treatment for cocaine addiction.
CHMP has recommended the approval of Afinitor based on data demonstrating that (when compared with placebo) Afinitor more than doubled the time without tumor growth or death in
Under the terms of the restructured deal, BioMarin has acquired full ownership of the DMD program, including the preclinical candidate, SMT C1100. BioMarin has assumed all future preclinical
Before joining B Riley in September 2008, McQuay employed for 10 years as managing director investment banking at A. G. Edwards & Sons, Inc., where he specialized in
Debasish Roychowdhury, Senior Vice President and Head of Medicines Development at GlaxoSmithKline Oncology, said: The committee’s positive vote in support of ofatumumab is a potential milestone for patients
BIBW 2992 is a novel tyrosine kinase inhibitor that acts by irreversibly blocking the EGFR /HER2 receptors, which are promoters of tumour growth. BIBW 2992 has demonstrated preclinical
Following the positive report by CHMP, Lilly has also filed for approval of ‘pemetrexed’ in the same indication with the FDA. In the European Union and US, pemetrexed
Under the clinical trial, randomized and blinded study aims to determine the optimal dosage of both VE Patch and the H5N1 influenza vaccine injected concomitantly, when combined with
The settlement resolves the allegation that between 1995 and 2000, Aventis and its corporate predecessors knowingly misreported best prices for the steroid based anti inflammatory nasal sprays Azmacort,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.